Sunday, August 06, 2023 10:43:23 PM
I don’t know why you did what you just did today, but you know if people believe you’re a huge investor with more connections, you’ve just given traders a safe month to beat this stock without fear. For some reason, direct or indirect, you want there to be cheap shares in August.
The next logical window would have been 0 to 17 days from July 31 for an announcement depending on the submittal/acceptance choice, the next (if no announcement) window would start August 28. You just gave traders, shorts and others at least the month of August if not also early September to playyyyy.
Fortunately, you’ve struck out three times in April, May, June (and probably July), so why wouldn’t you be wrong the other way around. Christ you’re batting 0.0000 on MAA submission month (for three or four month’s successively) now why wouldn’t you expect people to think you’ll be wrong in August (and early September) on NONSUBMISSION month. Seems to me, they should.
The next logical window would have been 0 to 17 days from July 31 for an announcement depending on the submittal/acceptance choice, the next (if no announcement) window would start August 28. You just gave traders, shorts and others at least the month of August if not also early September to playyyyy.
Fortunately, you’ve struck out three times in April, May, June (and probably July), so why wouldn’t you be wrong the other way around. Christ you’re batting 0.0000 on MAA submission month (for three or four month’s successively) now why wouldn’t you expect people to think you’ll be wrong in August (and early September) on NONSUBMISSION month. Seems to me, they should.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
